At the time of writing, Calidi Biotherapeutics Inc [CLDI] stock is trading at $1.35, up 14.42%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CLDI shares have gain 23.85% over the last week, with a monthly amount glided 25.00%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Calidi Biotherapeutics Inc [AMEX: CLDI] stock has seen the most recent analyst activity on November 22, 2023, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $11. Previously, Robert W. Baird started tracking the stock with Outperform rating on October 09, 2023, and set its price target to $9.
For the past year, the stock price of Calidi Biotherapeutics Inc fluctuated between $0.73 and $26.30. Currently, Wall Street analysts expect the stock to reach $5.5 within the next 12 months. Calidi Biotherapeutics Inc [AMEX: CLDI] shares were valued at $1.35 at the most recent close of the market. An investor can expect a potential return of 307.41% based on the average CLDI price forecast.
Analyzing the CLDI fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -2.89, Equity is 2.08 and Total Capital is 4.47. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.52.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1633 points at the first support level, and at 0.9767 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5233, and for the 2nd resistance point, it is at 1.6967.
Ratios To Look Out For
It is important to note that Calidi Biotherapeutics Inc [AMEX:CLDI] has a current ratio of 0.12. As well, the Quick Ratio is 0.12, while the Cash Ratio is 0.07.
